Close

Deutsche Bank Starts Genesis Healthcare (GEN) at Hold

March 6, 2015 7:32 AM EST
Get Alerts GEN Hot Sheet
Price: $22.30 +0.90%

Rating Summary:
    8 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 10
Join SI Premium – FREE

Deutsche Bank initiated coverage on Genesis Healthcare (NYSE: GEN) with a Hold rating and a price target of $8.00.

Analyst Dana Nentin said, "While we see equity upside through the company’s focus on (1) improving skilled mix through its unique bifurcation strategy and development of specialized units, (2) continued momentum in its contract therapy business, and (3) upside opportunities with SKH deal synergies, we find it hard to justify a Buy rating at this point due to its trading liquidity, private equity overhang, and concentration in SNFs (especially in the context of potential SNF payment reform)."

For an analyst ratings summary and ratings history on GenOn Energy click here. For more ratings news on GenOn Energy click here.

Shares of GenOn Energy closed at $7.11 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

Deutsche Bank